U.S. flag

An official website of the United States government

NM_000249.4(MLH1):c.131C>G (p.Ser44Cys) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Nov 28, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001010982.3

Allele description [Variation Report for NM_000249.4(MLH1):c.131C>G (p.Ser44Cys)]

NM_000249.4(MLH1):c.131C>G (p.Ser44Cys)

Gene:
MLH1:mutL homolog 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p22.2
Genomic location:
Preferred name:
NM_000249.4(MLH1):c.131C>G (p.Ser44Cys)
HGVS:
  • NC_000003.12:g.36996633C>G
  • NG_007109.2:g.8284C>G
  • NG_008418.1:g.1672G>C
  • NM_000249.4:c.131C>GMANE SELECT
  • NM_001167617.3:c.-159C>G
  • NM_001167618.3:c.-593C>G
  • NM_001167619.3:c.-501C>G
  • NM_001258271.2:c.131C>G
  • NM_001258273.2:c.-517+2970C>G
  • NM_001258274.3:c.-738C>G
  • NM_001354615.2:c.-496C>G
  • NM_001354616.2:c.-501C>G
  • NM_001354617.2:c.-593C>G
  • NM_001354618.2:c.-593C>G
  • NM_001354619.2:c.-593C>G
  • NM_001354620.2:c.-159C>G
  • NM_001354621.2:c.-686C>G
  • NM_001354622.2:c.-799C>G
  • NM_001354623.2:c.-723+2743C>G
  • NM_001354624.2:c.-696C>G
  • NM_001354625.2:c.-599C>G
  • NM_001354626.2:c.-696C>G
  • NM_001354627.2:c.-696C>G
  • NM_001354628.2:c.131C>G
  • NM_001354629.2:c.131C>G
  • NM_001354630.2:c.131C>G
  • NP_000240.1:p.Ser44Cys
  • NP_000240.1:p.Ser44Cys
  • NP_001245200.1:p.Ser44Cys
  • NP_001341557.1:p.Ser44Cys
  • NP_001341558.1:p.Ser44Cys
  • NP_001341559.1:p.Ser44Cys
  • LRG_216t1:c.131C>G
  • LRG_216:g.8284C>G
  • LRG_216p1:p.Ser44Cys
  • NC_000003.11:g.37038124C>G
  • NM_000249.3:c.131C>G
Protein change:
S44C
Links:
dbSNP: rs63751109
NCBI 1000 Genomes Browser:
rs63751109
Molecular consequence:
  • NM_001167617.3:c.-159C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001167618.3:c.-593C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001167619.3:c.-501C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001258274.3:c.-738C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354615.2:c.-496C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354616.2:c.-501C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354617.2:c.-593C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354618.2:c.-593C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354619.2:c.-593C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354620.2:c.-159C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354621.2:c.-686C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354622.2:c.-799C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354624.2:c.-696C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354625.2:c.-599C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354626.2:c.-696C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354627.2:c.-696C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001258273.2:c.-517+2970C>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354623.2:c.-723+2743C>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000249.4:c.131C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001258271.2:c.131C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354628.2:c.131C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354629.2:c.131C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354630.2:c.131C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001171255Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Nov 28, 2018)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Human MutL homolog (MLH1) function in DNA mismatch repair: a prospective screen for missense mutations in the ATPase domain.

Ellison AR, Lofing J, Bitter GA.

Nucleic Acids Res. 2004 Oct 8;32(18):5321-38. Print 2004.

PubMed [citation]
PMID:
15475387
PMCID:
PMC524276

Details of each submission

From Ambry Genetics, SCV001171255.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The p.S44C variant (also known as c.131C>G), located in coding exon 2 of the MLH1 gene, results from a C to G substitution at nucleotide position 131. The serine at codon 44 is replaced by cysteine, an amino acid with dissimilar properties. In a functional study using Saccharomyces cerevisiae yeast, this alteration was found to confer a pronounced loss of mismatch repair function (Ellison AR et al. Nucleic Acids Res., 2004 Oct;32:5321-38). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. In addition, this alteration is predicted to be deleterious by MAPP-MMR in silico analyses (Chao EC et al. Hum. Mutat. 2008 Jun;29:852-60). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024